Quick Facts

• May help with symptoms related to excess stomach acid.
• May assist in the relief of heartburn and acid indigestion.
• Intended to ease discomfort associated with gas and bloating.

Gelusil MPS Tablet is utilized for the symptomatic relief of conditions related to excessive stomach acid. Its primary use is to assist in neutralizing existing acid in the stomach, which can help mitigate the feeling of heartburn and acid indigestion.

This medication is a supportive option for managing symptoms of hyperacidity that may be associated with various gastrointestinal concerns. It may also provide relief from discomfort and pressure associated with flatulence and bloating.

Relief of these symptoms is intended for occasional use. Antacid and anti-gas combinations are used for the management of these forms of gastric distress. Consult a healthcare professional if symptoms persist or worsen over time, as this may indicate a need for further evaluation.

Regulatory References

1. NIH MedlinePlus guidance

Official Population Eligibility for Gelusil MPS Tablet

Regulatory documentation defines population eligibility for Gelusil MPS Tablet (Aluminium Hydroxide, Magnesium Hydroxide, Simethicone) through absolute exclusions and specific restrictions based on age, physiological status, and underlying conditions.

Contraindications (Must Not Use) The medicine is strictly contraindicated for any patient with a known hypersensitivity or allergy to Aluminium Hydroxide, Magnesium Hydroxide, Simethicone, or any inactive component of the formulation.

Age-Related Eligibility Use is established for adults and children 12 years of age and older under standard labeled conditions. The label specifies that children under 12 years of age are a restricted group and require consultation with a health professional before use.

Conditional Use (Requires Professional Consultation) Several patient populations are advised to consult a health professional before using this product, defining a conditional eligibility status:

• Kidney Disease/Renal Impairment: Consultation is mandatory due to the risk of impaired clearance, which could lead to the accumulation of aluminium and magnesium.
• Pregnancy and Lactation: Individuals who are pregnant or breastfeeding must ask a health professional before taking the medicine.
• Other Restrictions: Patients on a magnesium-restricted diet or those taking prescription drugs should also seek professional advice prior to use.

Interactions with other medicines and products

Gelusil MPS Tablet, composed of Aluminum Hydroxide and Magnesium Hydroxide, primarily interacts with other medications through two established physicochemical mechanisms: chelation and elevation of gastric pH.

These interactions are not metabolic (CYP-mediated) but rather affect the absorption of concurrently administered drugs in the gastrointestinal tract, leading to reduced systemic exposure of the co-administered medication.

Clinically Significant Pharmacokinetic Interactions

Mechanism	Drug Classes Affected (Examples)
Chelation (Cation Binding)	Tetracyclines ( Doxycycline), Quinolone antibiotics ( Ciprofloxacin), Iron Preparations
pH Elevation (Reduced Dissolution)	Thyroid Hormones ( Levothyroxine), Antifungal Agents ( Itraconazole)

Timing and Separation Requirements

Regulatory information emphasizes the need for timing separation to mitigate absorption interference. Patients taking oral medications that are susceptible to binding or pH changes are advised to administer them 1 to 2 hours before or after taking Gelusil MPS Tablet.

Food and Population-Specific Notes

A specific interaction occurs with Citrate-containing foods or beverages, which significantly increases the absorption of Aluminum. This interaction is especially important for patients with renal impairment, where reduced Aluminum and Magnesium clearance poses a risk of toxicity. Warnings also exist regarding the potential for physical interference when co-administered with high-protein enteral feedings.

The mechanism of action for this combination medication is confined entirely to the gastrointestinal lumen, operating through complementary chemical and physical domains. The antacid components, Aluminium Hydroxide and Magnesium Hydroxide, function as direct chemical buffering agents. They rapidly react with existing hydrochloric acid ( HCl), resulting in the ionic exchange of H^+ and a transient rise in gastric pH. This pH increase triggers a critical downstream effect: the immediate deactivation of the enzyme Pepsin, thereby suppressing its proteolytic activity.

Concurrently, Simethicone introduces a purely physical mechanism by lowering the surface tension within the gut contents. This alteration causes stable gas bubbles to coalesce into larger gas pockets. This modification in gas dynamics supports the formation of free gas for physiological elimination, influencing the mechanical forces of pressure and distension exerted on the surrounding tissue. Furthermore, the downarrow motility property of the aluminium ion is counterbalanced by the uparrow motility property of the magnesium ion, promoting synergistic homeostatic modulation of GI transit. The action provides transient physiological modulation as it addresses only the existing HCl and does not inhibit continuous acid production.

How to Use Gelusil MPS Tablet

This section describes the administration guidelines for the Gelusil MPS combination tablet. The information outlines the standard approach to dosage and administration.

---

Administration Scope

Rule Category	Official Instruction
Route of administration	The medicine is taken via the oral route (by mouth).
Dosing schedule (Adults)	For adults and children 12 years of age and over, the single dose is 2 to 4 tablets.
Preparation requirements	The tablet must be chewed thoroughly before swallowing for proper administration.
Age-group administration rules	Use in children under 12 years of age requires consultation with a physician.
Special procedural conditions	Do not take more than 12 tablets in a 24-hour period.

---

Instruction Classifications (High-level)

The regimen for this antacid and anti-gas combination is based on symptomatic use, rather than a fixed daily schedule.

Classification	Description
Administration method type	Oral, requiring active consumption (chewable tablet).
Frequency pattern	As-needed (PRN) use; the dose may be repeated hourly if symptoms recur.
Use-context constraints	The use of the maximum daily dosage (12 tablets) is not to exceed two consecutive weeks without the advice and supervision of a health professional.

---

Resulting Procedural Structure

The instructions establish a clear, short-term usage protocol:

• Take the prescribed amount of 2 to 4 tablets as required.
• The dosage form must be chewed thoroughly before it is swallowed.
• Dosage may be repeated hourly only if symptoms persist, while remaining strictly within the 12-tablet maximum for any 24-hour period.

This protocol defines the standardized, time-limited usage of the medicine.

Overview of Clinical Research

Clinical evidence for the combination of Aluminum Hydroxide, Magnesium Hydroxide, and Simethicone focuses primarily on the management of symptoms related to hyperacidity, such as heartburn and acid indigestion, and discomfort caused by gas and bloating.

Studies involving this combination generally demonstrate its ability to neutralize excess stomach acid. The inclusion of magnesium hydroxide is commonly observed in formulations with aluminum hydroxide to help minimize gastrointestinal motility side effects (e.g., constipation linked to aluminum salts and diarrhea linked to magnesium salts) that can occur when either component is used alone.

Efficacy and Safety Profile

Research has investigated the effects of the combined antacid components on gastric pH levels. The antacids work to rapidly neutralize hydrochloric acid in the stomach, which can provide symptomatic relief from acid-related conditions. Simethicone, the anti-gas agent, has been studied for its function in reducing gas pockets in the gastrointestinal tract, supporting its role in alleviating bloating and pressure.

• Study Focus: The efficacy of antacids similar to Gelusil MPS has been explored in clinical settings for rapid relief from acid-related issues, including in cases of breakthrough heartburn occurring between doses of longer-acting acid-reducing medications.
• Safety Findings: The components are generally considered well-tolerated in clinical use when taken as directed. However, due to the elimination pathways of aluminum and magnesium, special consideration is given in clinical guidelines for individuals with renal impairment, as monitoring of plasma levels may be necessary during prolonged or high-dose therapy.

Overall, the combination is supported by research for its dual action in addressing both acid and gas symptoms associated with common dyspepsia.

Common questions about Gelusil MPS Tablet (FAQ)

---

Q: What happens if I miss a dose of Gelusil MPS?

Since this product is for as-needed use, missing a dose typically does not require a specific action. If you are following a specific schedule provided by your doctor, regulatory guidance indicates that if a dose is missed, it should be taken as soon as remembered. However, if it is almost time for your next dose, the general recommendation is to skip the missed dose to avoid taking a double dose.

---

Q: What are the signs of an overdose of Gelusil MPS?

Official warnings state that it is important to seek medical help immediately in case of suspected overdose. While uncommon with standard use, high-dose or prolonged use can potentially lead to an accumulation of minerals. Signs of potential accumulation can include confusion, muscle weakness, or irregular heartbeat.

---

Q: What are the symptoms Gelusil MPS is specifically meant to treat?

Regulatory documents indicate that this medication is specifically intended to relieve symptoms of hyperacidity and gas. These typically include heartburn, sour stomach, acid indigestion, and the uncomfortable feelings of bloating and pressure caused by gas.

---

Q: What is the best time to take Gelusil MPS for heartburn relief (e.g., before or after meals)?

The directions for use indicate that the medicine should be taken when symptoms return, confirming its primary role is as-needed for symptomatic relief. Antacids are often used after meals and before bedtime to neutralize acid. Always follow the specific instructions from your healthcare provider or the product label regarding timing.

---

Q: What ingredients are in Gelusil MPS Tablet?

According to the official product information, the active ingredients are a combination of Aluminum Hydroxide, Magnesium Hydroxide, and Simethicone. Regulatory labeling focuses on the active components, but a complete list of all ingredients, including inactive components like flavorings, is found on the product packaging.

---

Q: Is it safe to give Gelusil MPS to children?

Official labeling establishes the use of this product for adults and children 12 years of age and older. Use in children under 12 years of age is restricted, and the official label advises consultation with a doctor before use.

How to Store and Dispose of Gelusil MPS Tablet

The official labeling for Gelusil MPS Chewable Tablets defines specific storage and handling requirements to maintain product stability and ensure safety.

---

Storage Requirements

Condition	Regulatory Statement
Temperature	Store below 30 C (86 F).
Packaging	Do not use if the blister or printed foil seal is broken.
Child Safety	Keep this product out of reach of children.

---

Disposal Guidance

The product label does not contain unique, mandated instructions for the final disposal of unused or expired tablets. As a non-hazardous, over-the-counter medicine, general guidance from health authorities should be followed. This typically recommends using a drug take-back program or, if unavailable, mixing the medicine with an undesirable substance, sealing it in a container, and placing it in household trash.